Revolution Medicines (RVMD) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to -$305.2 million.
- Revolution Medicines' Profit After Tax fell 9528.43% to -$305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$961.0 million, marking a year-over-year decrease of 6946.64%. This contributed to the annual value of -$600.1 million for FY2024, which is 3752.03% down from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' Profit After Tax is -$305.2 million, which was down 9528.43% from -$247.8 million recorded in Q2 2025.
- Revolution Medicines' 5-year Profit After Tax high stood at -$37.2 million for Q1 2021, and its period low was -$305.2 million during Q3 2025.
- In the last 5 years, Revolution Medicines' Profit After Tax had a median value of -$98.3 million in 2023 and averaged -$117.8 million.
- In the last 5 years, Revolution Medicines' Profit After Tax plummeted by 727.28% in 2022 and then crashed by 18587.08% in 2023.
- Quarter analysis of 5 years shows Revolution Medicines' Profit After Tax stood at -$52.7 million in 2021, then decreased by 7.27% to -$56.5 million in 2022, then tumbled by 185.87% to -$161.5 million in 2023, then dropped by 20.45% to -$194.6 million in 2024, then tumbled by 56.86% to -$305.2 million in 2025.
- Its last three reported values are -$305.2 million in Q3 2025, -$247.8 million for Q2 2025, and -$213.4 million during Q1 2025.